Apr 7, 2026 09:31AM

Apr 7, 2026 08:05AM

Jan 6, 2026 07:26AM

Oct 16, 2025 06:05AM

Oct 1, 2025 07:30AM

Sep 17, 2025 07:32AM

Sep 10, 2025 03:07PM Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey

Jul 15, 2025 03:25PM

May 5, 2025 08:00AM

Apr 15, 2025 08:01AM

Apr 10, 2025 08:41AM

Apr 10, 2025 08:37AM

Mar 7, 2025 08:01AM

Mar 6, 2025 07:00AM Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States

Feb 24, 2025 07:00AM

Dec 2, 2024 07:00AM

Sep 25, 2024 01:05AM

Aug 29, 2024 01:13AM

May 21, 2024 08:00AM

Mar 14, 2024 03:29PM

Feb 29, 2024 09:56AM Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®

Jul 3, 2023 12:40PM

Jul 28, 2021 11:29PM

Aug 31, 2020 06:00AM

Jul 21, 2020 02:00AM

Jun 11, 2020 06:35PM

Mar 9, 2020 08:05AM

Mar 9, 2020 08:00AM U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review

Dec 2, 2019 07:00AM

Oct 19, 2018 09:31AM

Oct 19, 2018 09:30AM

Sep 21, 2018 09:30AM

Jun 4, 2018 04:52PM

Jun 1, 2018 05:18PM

Dec 29, 2017 01:30AM Biocon and Mylan's Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through their Partner Libbs

Dec 1, 2017 11:33AM

Dec 1, 2017 11:31AM

Nov 30, 2017 12:55PM

Jul 13, 2017 05:05PM

Jul 13, 2017 05:02PM

Feb 16, 2017 08:13AM

Feb 16, 2017 08:08AM U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review

Jan 11, 2017 08:01AM

Jan 11, 2017 08:00AM

Dec 27, 2016 08:06AM

Dec 27, 2016 08:00AM

323,751 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All